All Stories

  1. Comments to: Restoration of photoreceptors in eyes with diabetic macular edema

    Article • European Journal of Ophthalmology, January 2018, SAGE Publications

    Professor Mihai Calugaru

  2. Comments to: Real-World Outcomes of Anti-VEGF Treatment for Retinal Vein Occlusion in Portugal

    Article • European Journal of Ophthalmology, August 2017, SAGE Publications

    Professor Mihai Calugaru

  3. Comments to: Visual and Anatomic Outcomes after Conversion to Aflibercept in Neovascular Age-Related Macular Degeneration: 12-Month Results

    Article • European Journal of Ophthalmology, June 2017, SAGE Publications

    Professor Mihai Calugaru

  4. Comments to: Clinical Experience of Switching Anti-VEGF Therapy from Ranibizumab to Aflibercept in Age-Related Choroidal Neovascularization

    Article • European Journal of Ophthalmology, May 2017, SAGE Publications

    Professor Mihai Calugaru

  5. Comments to: Ranibizumab for Persistent Diabetic Macular Edema after Bevacizumab Treatment

    Article • European Journal of Ophthalmology, May 2017, SAGE Publications

    Professor Mihai Calugaru

  6. Clinical Efficacy and Safety of Ranibizumab Versus Dexamethasone for Central Retinal Vein Occlusion (COMRADE C): A European Label Study

    Article • American Journal of Ophthalmology, September 2016, Elsevier

    Professor Mihai Calugaru

  7. Conversion to Aflibercept After Prior Anti-VEGF Therapy for Persistent Diabetic Macular Edema

    Article • American Journal of Ophthalmology, August 2016, Elsevier

    Professor Mihai Calugaru

  8. Comment on: 'Combination of peripheral laser photocoagulation with intravitreal bevacizumab in naive eyes with macular edema secondary to CRVO: prospective randomized study'

    Article • Eye, June 2016, Nature

    Professor Mihai Calugaru

  9. Comment on: ‘Central retinal vein occlusion: modifying current treatment protocols’

    Article • Eye, April 2016, Nature

    Professor Mihai Calugaru

  10. Comments to: Long-Term Efficacy and Safety of Intravitreal Dexamethasone Implant for the Treatment of Diabetic Macular Edema

    Article • European Journal of Ophthalmology, April 2016, SAGE Publications

    Professor Mihai Calugaru

  11. Comments To: Response to Bevacizumab after Treatment with Aflibercept in Eyes with Neovascular AMD

    Article • European Journal of Ophthalmology, April 2016, SAGE Publications

    Professor Mihai Calugaru

  12. Comment on: ‘Intravitreal aflibercept for macular oedema secondary to central retinal vein occlusion in patients with prior treatment with bevacizumab or ranibizumab’

    Article • Eye, February 2016, Nature

    Professor Mihai Calugaru

  13. Pro-permeability Factors After Dexamethasone Implant in Retinal Vein Occlusion; The Ozurdex for Retinal Vein Occlusion (ORVO) Study

    Article • American Journal of Ophthalmology, January 2016, Elsevier

    Professor Mihai Calugaru

  14. Bevacizumab treatment of macular edema in CRVO and BRVO: long-term follow-up (BERVOLT study: bevacizumab for RVO long-term follow-up)

    Article • Graefe s Archive for Clinical and Experimental Ophthalmology, November 2015, Springer Science + Business Media

    Professor Mihai Calugaru

  15. Re: Yeh et al.: Ophthalmic Technology Assessment: therapies for macular edema associated with central retinal vein occlusion: a report by the American Academy of Ophthalmology (Ophthalmology 2015;122:769-78)

    Article • Ophthalmology, November 2015, Elsevier

    Professor Mihai Calugaru

  16. Comment on ‘The Royal College of Ophthalmologists Guidelines on retinal vein occlusions: executive summary’

    Article • Eye, October 2015, Nature

    Professor Mihai Calugaru

  17. Patterns of ranibizumab and aflibercept treatment of central retinal vein occlusion in routine clinical practice in the USA

    Article • Eye, May 2015, Springer Science + Business Media

    Professor Mihai Calugaru

  18. Intravitreal Aflibercept for Macular Edema Secondary to Central Retinal Vein Occlusion: 18-Month Results of the Phase 3 GALILEO Study

    Article • American Journal of Ophthalmology, March 2015, Elsevier

    Professor Mihai Calugaru

  19. Intravitreal Bevacizumab in Acute Central/Hemicentral Retinal Vein Occlusions: Three-Year Results of a Prospective Clinical Study

    Article • Journal of Ocular Pharmacology and Therapeutics, March 2015, Mary Ann Liebert Inc

    Professor Mihai Calugaru

  20. Effect of calcium dobesilate on occurrence of diabetic macular oedema (CALDIRET study): randomised, double-blind, placebo-controlled, multicentre trial

    Article • The Lancet, April 2009, Elsevier

    Professor Mihai Calugaru

  21. Exuberant epibulbar tumor penetrating into the orbit in xeroderma pigmentosum

    Article • Graefe s Archive for Clinical and Experimental Ophthalmology, January 1992, Springer Science + Business Media

    Professor Mihai Calugaru

  22. Das Partnerauge bei einseitigem malignen Glaukom

    Article • Klinische Monatsblätter für Augenheilkunde, March 1991, Thieme Publishing Group

    Professor Mihai Calugaru

  23. Die Wirkung von Levobunolol-Augentropfen auf den trabekulären Kammerwasserabfluß beim chronischen Glaucoma simplex

    Article • Klinische Monatsblätter für Augenheilkunde, March 1989, Thieme Publishing Group

    Professor Mihai Calugaru

  24. Die Wirksamkeit der transkutanen Levatorresektion bei der kongenitalen Ptosis des Oberlides*

    Article • Klinische Monatsblätter für Augenheilkunde, August 1985, Thieme Publishing Group

    Professor Mihai Calugaru

  25. Nystagmus héréditaire et maladies démyélinisantes primaires

    Article • Journal of the Neurological Sciences, July 1971, Elsevier

    Professor Mihai Calugaru